Enhancing Safety in Healthcare: Introduction of the EQUASHIELD® Safety Platform
EQUASHIELD®, acknowledged as a leading entity in the field of Closed System Transfer Devices (CSTD) and advanced pharmacy automation, is geared up to introduce its latest groundbreaking solution at the ASHP Midyear Clinical Meeting in Las Vegas from December 8 to 10, 2025. This event is poised to showcase the EQUASHIELD® Safety Platform, which brings together avant-garde technology designed to elevate safety protocols and efficiency in handling hazardous drugs.
In healthcare settings, safety is paramount, especially when dealing with hazardous drugs. The EQUASHIELD® Safety Platform integrates their acclaimed CSTD with the Mundus HD automated compounding system and advanced IV Workflow software. This integration is crafted to minimize risk while enhancing productivity among healthcare professionals. The focus of this platform is not only on safety but also on streamlining workflows to meet the high demands of patient care.
The Integrated System: Features and Benefits
The EQUASHIELD® Safety Platform combines various elements into a seamless production line for compounding that emphasizes safety as the core mission. Every stage of drug preparation and administration is carefully monitored through a closed, automated system. This drastically reduces the chances of human error while ensuring that every dose is engineered with precision.
The platform's design employs sophisticated image processing along with bi-directional Electronic Medical Record (EMR) connectivity to provide thorough verification in real time. The system standardizes every component of the workflow, commencing from the electronic order intake to the pharmacist's final verification and subsequent approval for dispensing. Each medication undergoes a complete automated safety check, significantly reducing errors associated with manual processes. For instance, issues like drug selection inconsistencies, inaccurate volume calculations, and incorrect diluent choices have a considerably lower risk of occurrence.
One of the platform's key selling points lies in its straightforward implementation. It merges effortlessly with existing biological safety cabinets, preventing the need for extensive financial investments, which in turn makes the advantages of automation more approachable for clinical pharmacies.
In practical terms, the EQUASHIELD® CSTD maintains a robust leak-proof barrier that safeguards against contamination and exposure. Its unique pre-bonded Syringe Unit is designed to minimize accidental disconnections, while an encapsulated plunger rod effectively traps harmful vapors and aerosols. When linked with the Mundus HD's automation and IV Workflow software, these elements ensure that compounding processes are not only automated but also adhere strictly to accuracy requirements, establishing a benchmark for dependable operation in pharmacy environments.
This level of innovation is reinforced by EQUASHIELD®’s legacy, as the company has been the foremost choice among healthcare providers for CSTD technology for the past seven years. Its reputation for user-friendliness, supplemented by exceptional service support, has established it as a trusted component in pharmacy solutions worldwide.
Statement from the Leadership
“By integrating closed-system safety with automated processes, the EQUASHIELD® Safety Platform sets a new standard in how healthcare institutions manage hazardous drug handling,” remarked Matt Stuckert, the President and General Manager at EQUASHIELD®. He added, “Our collective aim is to shield healthcare staff from risks, prevent operational errors, and enhance the overall outcomes for patients.”
Live Demonstrations at ASHP 2025
EQUASHIELD® warmly invites all attendees of the ASHP Midyear Clinical Meeting to visit booth #2017 for live demonstrations of the EQUASHIELD® Safety Platform. Participants will have the opportunity to witness firsthand how this innovative design is poised to shape the future of safe and efficient drug compounding.
About EQUASHIELD®
Founded in 2009, EQUASHIELD® Compounding Technologies has emerged as a frontrunner in crafting solutions for both manual and automated compounding and administration tools that prioritize the safety of healthcare professionals encountering hazardous drugs. With its advanced CSTD and the Mundus HD automation platform, EQUASHIELD® is at the forefront of redefining safety, standard practices, and simplicity within hospital pharmacy workflows.
For additional insights and information, kindly visit
www.EQUASHIELD.com or reach out via email at [email protected]